CIK: 1821189 - Address: C/O Kymera Therapeutics, Inc., 500 North Beacon Street, 4Th Floor, Watertown, MA 02472
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/13/25 07:00
1/10/25
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOM.d212.080102660D
7/1/24 16:30
7/1/24
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOM.d1005.330193650D
6/20/24 08:30
6/18/24
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOM.d302.080142631D
1/2/24 17:43
1/2/24
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOM.d192.08091616D
11/6/23 18:00
11/3/23
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOM.d422.080203607D
8/8/23 16:30
8/8/23
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOM.d252.080122587D
12/8/22 18:11
12/8/22
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOM.d212.080102574D
10/17/22 20:09
10/17/22
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOM.d1242.0806012562D
5/3/22 19:27
5/3/22
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOM.d422.080204502D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact